198 related articles for article (PubMed ID: 33119213)
1. Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers.
Ramani NS; Chen H; Broaddus RR; Lazar AJ; Luthra R; Medeiros LJ; Patel KP; Rashid A; Routbort MJ; Stewart J; Tang Z; Bassett R; Manekia J; Barkoh BA; Dang H; Roy-Chowdhuri S
Cancer Cytopathol; 2021 May; 129(5):374-382. PubMed ID: 33119213
[TBL] [Abstract][Full Text] [Related]
2. Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation Sequencing.
Ramani NS; Patel KP; Routbort MJ; Alvarez H; Broaddus R; Chen H; Rashid A; Lazar A; Lucas FAS; Yao H; Manekia J; Dang H; Barkoh BA; Medeiros LJ; Luthra R; Roy-Chowdhuri S
Arch Pathol Lab Med; 2021 Nov; 145(11):1405-1412. PubMed ID: 33493304
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic utility of next-generation sequencing on FNA biopsies of melanocytic uveal lesions.
Han LM; Khanafshar E; Afshar AR; Calkins SM
Cancer Cytopathol; 2020 Jul; 128(7):499-505. PubMed ID: 32196967
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting the success of next-generation sequencing in cytology specimens.
Roy-Chowdhuri S; Goswami RS; Chen H; Patel KP; Routbort MJ; Singh RR; Broaddus RR; Barkoh BA; Manekia J; Yao H; Medeiros LJ; Staerkel G; Luthra R; Stewart J
Cancer Cytopathol; 2015 Nov; 123(11):659-68. PubMed ID: 26230354
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of next-generation sequencing for the identification of clinically relevant variants in cytology smears in lung adenocarcinoma.
Baum JE; Zhang P; Hoda RS; Geraghty B; Rennert H; Narula N; Fernandes HD
Cancer Cytopathol; 2017 Jun; 125(6):398-406. PubMed ID: 28272845
[TBL] [Abstract][Full Text] [Related]
6. Targeted RNA sequencing with touch imprint cytology samples for non-small cell lung cancer patients.
Seto K; Masago K; Fujita S; Haneda M; Horio Y; Hida T; Kuroda H; Hosoda W; Okubo KI
Thorac Cancer; 2020 Jul; 11(7):1827-1834. PubMed ID: 32372482
[TBL] [Abstract][Full Text] [Related]
7. Next-generation sequencing of cytologic preparations: An analysis of quality metrics.
Hwang DH; Garcia EP; Ducar MD; Cibas ES; Sholl LM
Cancer Cytopathol; 2017 Oct; 125(10):786-794. PubMed ID: 28727266
[TBL] [Abstract][Full Text] [Related]
8. Next generation sequencing in cytology.
Pisapia P; Pepe F; Sgariglia R; Nacchio M; Russo G; Conticelli F; Girolami I; Eccher A; Bellevicine C; Vigliar E; Malapelle U; Troncone G
Cytopathology; 2021 Sep; 32(5):588-595. PubMed ID: 33792981
[TBL] [Abstract][Full Text] [Related]
9. FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.
Treece AL; Montgomery ND; Patel NM; Civalier CJ; Dodd LG; Gulley ML; Booker JK; Weck KE
Cancer Cytopathol; 2016 Jun; 124(6):406-14. PubMed ID: 26882436
[TBL] [Abstract][Full Text] [Related]
10. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
Velizheva NP; Rechsteiner MP; Wong CE; Zhong Q; Rössle M; Bode B; Moch H; Soltermann A; Wild PJ; Tischler V
Cancer Cytopathol; 2017 Jan; 125(1):30-40. PubMed ID: 27636102
[TBL] [Abstract][Full Text] [Related]
11. Thyroid cytology smear slides: An untapped resource for ThyroSeq testing.
Nikiforova MN; Lepe M; Tolino LA; Miller ME; Ohori NP; Wald AI; Landau MS; Kaya C; Malapelle U; Bellevicine C; Troncone G; Nikiforov YE; Baloch Z
Cancer Cytopathol; 2021 Jan; 129(1):33-42. PubMed ID: 32697051
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cytocentrifugation supernatant fluid and formalin-fixed paraffin-embedded tissue for targeted next-generation sequencing.
Janaki N; Harbhajanka A; Michael CW; Bomeisl P; Wasman J; Atchley M; Miskiewicz K; Alouani D; Sadri N
Cancer Cytopathol; 2019 May; 127(5):297-305. PubMed ID: 30933438
[TBL] [Abstract][Full Text] [Related]
13. Preanalytic Variables in Cytology: Lessons Learned From Next-Generation Sequencing-The MD Anderson Experience.
Roy-Chowdhuri S; Stewart J
Arch Pathol Lab Med; 2016 Nov; 140(11):1191-1199. PubMed ID: 27333361
[TBL] [Abstract][Full Text] [Related]
14. Incorporating cytologic adequacy assessment into precision oncology workflow using telepathology: An institutional experience.
Al Zoughbi W; Kim D; Alperstein SA; Ohara K; Manohar J; Greco N; Khani F; Robinson BD; Rao RA; Elemento O; Mosquera JM; Siddiqui MT
Cancer Cytopathol; 2021 Nov; 129(11):874-883. PubMed ID: 33929788
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer.
Stoy SP; Segal JP; Mueller J; Furtado LV; Vokes EE; Patel JD; Murgu S
Clin Lung Cancer; 2018 May; 19(3):230-238.e2. PubMed ID: 29277564
[TBL] [Abstract][Full Text] [Related]
16. Use of cytology centrifuged supernatants improves cost and turnaround time for targeted next generation sequencing.
Gokozan H; Harbhajanka A; Bomeisl P; Michael CW; Sadri N
Diagn Cytopathol; 2020 Dec; 48(12):1167-1172. PubMed ID: 32697040
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer adrenal gland metastasis: Optimal fine-needle aspirate and touch preparation smear cellularity characteristics for successful theranostic next-generation sequencing.
Gleeson FC; Kipp BR; Levy MJ; Voss JS; Campion MB; Minot DM; Tu ZJ; Klee EW; Lazaridis KN; Kerr SE
Cancer Cytopathol; 2014 Nov; 122(11):822-32. PubMed ID: 25045116
[TBL] [Abstract][Full Text] [Related]
18. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
[TBL] [Abstract][Full Text] [Related]
19. Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid Tumors.
Goswami RS; Luthra R; Singh RR; Patel KP; Routbort MJ; Aldape KD; Yao H; Dang HD; Barkoh BA; Manekia J; Medeiros LJ; Roy-Chowdhuri S; Stewart J; Broaddus RR; Chen H
Am J Clin Pathol; 2016 Feb; 145(2):222-37. PubMed ID: 27124905
[TBL] [Abstract][Full Text] [Related]
20. Preanalytic variables in quality and quantity of nucleic acids extracted from FNA specimens of thyroid gland nodules collected in CytoLyt: Cellularity and storage time.
Heymann JJ; Yoxtheimer LM; Park HJ; Fernandez EM; Facey KE; Alperstein SA; Tran HV; Baek I; Scognamiglio T; Rennert H; Siddiqui MT; Song W
Cancer Cytopathol; 2020 Sep; 128(9):656-672. PubMed ID: 32267620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
